Simon N.r. Harford - 13 Jul 2021 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
13 Jul 2021
Net transactions value
-$3,432
Form type
4
Filing time
15 Jul 2021, 16:48:01 UTC
Next filing
12 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $3,432 -98 -0.77% $35.02 12,707 13 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 5,644 shares of common stock and 7,063 restricted stock units. Includes 609 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021.